From: Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study
Survivors n = 84 | Nonsurvivors n = 35 | P value | |
---|---|---|---|
Age (years) | 65 ± 14 | 71 ± 12 | 0.01* |
Male sex (%) | 54 (64.3) | 17 (48.6) | 0.15 |
Heart rate (bpm) | 94 ± 14 | 97 ± 16 | 0.36 |
SAP (mmHg) | 92 ± 12 | 91 ± 15 | 0.69 |
MAP (mmHg) | 66 ± 7 | 64 ± 7 | 0.19 |
DAP (mmHg) | 51 ± 7 | 49 ± 7 | 0.07 |
MPP (mmHg) | 53 ± 8 | 51 ± 9 | 0.26 |
CVP (mmHg) | 12 ± 3 | 13 ± 3 | 0.12 |
MPAP† (mmHg) | 28 ± 6 | 28 ± 6 | 0.89 |
PAOP† (mmHg) | 18 ± 5 | 18 ± 4 | 0.64 |
CPP† (mmHg) | 31 ± 7 | 30 ± 9 | 0.3 |
CI† (l/min/m2) | 2.7 ± 0.5 | 2.4 ± 0.4 | 0.003* |
CPI† (W/m2) | 0.39 ± 0.08 | 0.34 ± 0.38 | 0.005* |
SvO2† (%) | 64 ± 6 | 62 ± 9 | 0.14 |
SVRI (dyne*s/cm5/m2) | 1760 ± 664 | 1779 ± 357 | 0.89 |
Epinephrine# n = 50 (μg/h) | 61 ± 130 | 195 ± 317 | 0.03* |
Norepinephrine# n = 37 (μg/h) | 26 ± 85 | 17 ± 54 | 0.6 |
Dobutamine# n = 89 (mg/h) | 8 ± 7 | 10 ± 8 | 0.11 |
Milrinone# n = 14 (mg/h) | 0.07 ± 0.24 | 0.07 ± 0.25 | 0.99 |
Nitroprusside# (mg/h) | 1.87 ± 3.68 | 1.49 ± 2.75 | 0.6 |
Arterial lactate§ (mmol/l) | 4.1 ± 3.3 | 6.4 ± 4 | 0.002* |
Troponin T§ (μg/l) | 54 ± 103 | 114 ± 228 | 0.19 |
RRT (%) | 10 (11.9) | 12 (34.3) | 0.008* |
SOFA score§ | 10 ± 3 | 12 ± 3 | 0.007* |
SAPS II | 49 ± 15 | 61 ± 17 | < 0.001* |
ICU LOS (days) | 8.1 ± 9.8 | 5 ± 4.6 | 0.02* |